PHIO · Phio Pharmaceuticals Corp. · Exempt Offerings
$0.89
+0.00 (+0.21%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$10.36M
Shares
11.62M
Volume · Oct 21
82.45K
Avg daily vol (3M)
140.98K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-11-12 | New | Biotechnology | $25,931,342 | $1,415,796 | 06b |
| 2025-08-04 | New | Biotechnology | $5,080,826 | $232,149 | 06b |
| 2025-01-28 | New | Biotechnology | $6,382,020 | $265,918 | 06b |
| 2025-01-28 | New | Biotechnology | $3,660,000 | $152,500 | 06b |
| 2025-01-28 | New | Biotechnology | $5,000,010 | $208,334 | 06b |
| 2025-01-07 | New | Biotechnology | $480,000 | $30,000 | 06b |
| 2025-01-03 | New | Biotechnology | $1,314,650 | $54,649 | 06b |
| 2024-07-24 | New | Biotechnology | $6,358,543 | $136,322 | 06b |
| 2023-12-19 | New | Biotechnology | $5,399,124 | $532,563 | 06b |
| 2023-06-13 | New | Biotechnology | $10,907,728 | $2,999,373 | 06b |
| 2023-05-02 | New | Biotechnology | $4,010,519 | $4,010,519 | 06b |
| 2022-11-23 | New | Biotechnology | $1,750 | $1,750 | 06b |
| 2021-02-16 | New | Pharmaceuticals | $24,264,137 | $14,001,909 | 06b |
| 2020-04-14 | New | Pharmaceuticals | $4,375,011 | $4,375,011 | 06b |
| 2020-02-24 | New | Pharmaceuticals | $1,903,128 | $1,903,128 | 06b |
Showing 1–15 of 15 filings